Stay updated on Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s displayed revision version was updated from v3.5.2 to v3.5.3, indicating a site/interface version change rather than an edit to the study’s content.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:14.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0 from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:37:29.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision 3.5.0 has been added to the record history, and revision 3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:57.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page history shows a new site revision v3.4.3 added and the previous revision v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:19:03.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and an older funding-status notice and revision entry (v3.4.1) were removed as administrative updates.
    Difference
    0.7%
    Check dated 2026-02-11T11:47:51.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A site-wide notice about potential data delays due to a lapse in government funding was added, and the record version was updated from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-04T06:20:06.000Z thumbnail image

Stay in the know with updates to Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.